Ibnsina Pharma Co SAE EGX:ISPH:
IBNSINA PHARMA QTRLY CONSOL NET PROFIT EGP 255.9 MILLION
IBNSINA PHARMA QTRLY CONSOL NET SALES EGP 20.50 BILLION
Ibnsina Pharma Co SAE EGX:ISPH:
IBNSINA PHARMA QTRLY CONSOL NET PROFIT EGP 255.9 MILLION
IBNSINA PHARMA QTRLY CONSOL NET SALES EGP 20.50 BILLION
Follow Ibnsina Pharma into a list and get an email when it puts out news.
Follow Ibnsina Pharma